Historical record - last NADAC effective date: 6/21/2023
Product Information
QC CHILD PAIN RLF 160 MG/5 ML is a generic product labeled by Chain Drug Marketing Association, priced at $0.0209 per ML under NDC 63868017526. Its NADAC has been published 463 times since Nov 28, 2013.
Strength
160 mg/5mL
Manufacturer
Chain Drug Marketing AssociationNDC
63868017526
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
6/21/2023
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
10/31/2015
Price Statistics
The NADAC for QC CHILD PAIN RLF 160 MG/5 ML has been published 463 times since Nov 28, 2013, and over the history we have for it it has risen 3.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0209 per ML |
|---|---|
| All-time high | $0.0261 (Mar 15, 2023) |
| All-time low | $0.0178 (Jul 19, 2017) |
| Median price | $0.0197 |
| Average price | $0.0198 |
| Largest weekly change | +25.7% (Feb 22, 2023) |
| Weeks tracked | 463 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+0.5%
All
+3.9%
Last surveyed Jun 28, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC CHILD PAIN RLF 160 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for QC CHILD PAIN RLF 160 MG/5 ML, manufactured by Chain Drug Marketing Association, is $0.0209 per ML (NDC 63868017526), effective Jun 28, 2023.
How has the price of QC CHILD PAIN RLF 160 MG/5 ML changed over time?
Over the history we have for it, the NADAC for QC CHILD PAIN RLF 160 MG/5 ML has risen 3.9%. It has been tracked across 463 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QC CHILD PAIN RLF 160 MG/5 ML?
Since Nov 28, 2013, the NADAC for QC CHILD PAIN RLF 160 MG/5 ML has ranged from a low of $0.0178 (Jul 19, 2017) to a high of $0.0261 (Mar 15, 2023), with a median of $0.0197 per ML.
Are there cheaper alternatives to QC CHILD PAIN RLF 160 MG/5 ML?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILD PAIN-FEVER 160 MG/5 ML, is $0.0205 per ML — about 2% below QC CHILD PAIN RLF 160 MG/5 ML.
Who manufactures QC CHILD PAIN RLF 160 MG/5 ML?
QC CHILD PAIN RLF 160 MG/5 ML (NDC 63868017526) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.